cheng wang
Changzhou University
Changzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
chong-zhi wang
The University of Chicago
Chicago, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
feng wang
Affiliated Hospital of Nantong University
Nantong, China
Review Editor
Pharmacology of Anti-Cancer Drugs
hecheng wang
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
hongbo wang
Yantai University
Yantai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
jing wang
First Affiliated Hospital of Chongqing Medical University
Chongqing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
jing wang
Hunan Cancer Hospital, Xiangya School of Medicine, Central South University
Changsha, China
Review Editor
Pharmacology of Anti-Cancer Drugs
ke wang
Jiangsu Institute of Nuclear Medicine
Wuxi, China
Review Editor
Pharmacology of Anti-Cancer Drugs
ling wei wang
Tongji University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
liyuan wang
Peking University Third Hospital
Haidian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
ruo wang
Comprehensive Breast Health Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
shibing wang
Zhejiang Provincial People's Hospital
Hangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
wen wang
Xuanwu Hospital, Capital Medical University
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yuyan wang
Beijing Cancer Hospital
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhi-bin wang
Hunan Cancer Hospital, Xiangya School of Medicine, Central South University
Changsha, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhiyong wang
Sun Yat-sen University
Guangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs